Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

493
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cochlear Implants in Inner Ear Malformations-Considerations Regarding the Role of Imaging in Preoperative Evaluation.

Healthcare (Basel, Switzerland)·2026
Same author

Oral Health and Gut-Targeted Microbial Marker Changes Associated with Prolonged Hospitalization in Cardiac Patients: An Integrative Risk Analysis.

Life (Basel, Switzerland)·2026
Same author

Hydrogels-Advanced Polymer Platforms for Drug Delivery.

Polymers·2026
Same author

Lipid, Metabolomic and Gut Microbiome Profiles in Long-Term-Hospitalized Cardiac Patients-An Observational and Retrospective Study.

Diagnostics (Basel, Switzerland)·2025
Same author

A Systemic Perspective of the Link Between Microbiota and Cardiac Health: A Literature Review.

Life (Basel, Switzerland)·2025
Same author

Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Apr 28, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

AI-Based Predictive Models for Cardiogenic Shock in STEMI: Real-World Data for Early Risk Assessment and Prognostic

Elena Stamate1, Anisia-Luiza Culea-Florescu2, Mihaela Miron3

  • 1Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.

Journal of Clinical Medicine
|June 13, 2025
PubMed
Summary

Machine learning models can predict cardiogenic shock (CS) risk in ST-elevation myocardial infarction (STEMI) patients early. This aids in timely intervention and prioritizing urgent angiography, potentially improving survival rates.

Keywords:
STEMIangiography prioritizationcardiogenic shockearly triagemachine learningpredictive models

More Related Videos

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.1K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

6.9K

Related Experiment Videos

Last Updated: Apr 28, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.1K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

6.9K

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Cardiogenic shock (CS) is a severe complication of ST-elevation myocardial infarction (STEMI), leading to high in-hospital mortality.
  • Early identification and intervention are crucial for improving patient outcomes in STEMI.
  • Current reperfusion strategies have not significantly reduced CS-related mortality.

Purpose of the Study:

  • To evaluate the effectiveness of machine learning (ML) models in predicting the risk of CS during early care phases (prehospital, ED, cardiology-on-call).
  • To assess the utility of ML for accurate triage and prioritization of STEMI patients requiring urgent angiography.
  • To identify key clinical features that predict CS risk in STEMI patients.

Main Methods:

  • Development and evaluation of various ML models, including Extra Trees, Support Vector Machine, and Random Forest classifiers.
  • Assessment of model performance using metrics such as accuracy, precision, recall, F1-score, and MCC across different care phases.
  • Identification of critical predictive features from routinely available clinical data.

Main Results:

  • Extra Trees classifier showed high performance in the prehospital phase (ACC 0.9062).
  • Support Vector Machine (ACC 78.12%) and Random Forest (ACC 81.25%) demonstrated strong predictive capabilities in the ED and cardiology-on-call phases, respectively.
  • Killip class, ECG rhythm, creatinine, potassium, and renal dysfunction markers were key predictors; models showed greatest utility in prehospital and ED settings.

Conclusions:

  • ML-based predictive models are valuable tools for early risk stratification of STEMI patients at risk for CS.
  • Implementation of ML-driven tools can enhance decision-making in early STEMI care pathways.
  • These tools have the potential to improve survival rates through faster and more accurate patient management, particularly in time-sensitive environments.